Prof. Dr. Johnny Huard, Steadman Philippon Research Institute, United States
Dr. Johnny Huard, PhD, is an internationally recognized pioneer in regenerative medicine and stem cell research. He currently serves as the Chief Scientific Officer and Director of the Center for Regenerative and Personalized Medicine at the Steadman Philippon Research Institute, Vail, Colorado. In addition, Dr. Huard holds key leadership positions as Director of Research at ProofPoint Biologics and Professor in the Department of Surgery at Duquesne University. With over three decades of impactful research and innovation, he is most renowned for his groundbreaking work on muscle-derived stem cells (MDSCs), which has profoundly influenced regenerative therapies across orthopedics, urology, cardiology, and beyond.
đź”·Professional Profile
Scopus Profile
Google Scholar
🏆Strengths for the Award
Dr. Johnny Huard is an internationally acclaimed leader in regenerative medicine and gene therapy, particularly known for his pioneering work in muscle-derived stem cells (MDSCs). With a Ph.D. in Neurobiology from Laval University (1993), Dr. Huard has consistently advanced the frontiers of stem cell biology, musculoskeletal regeneration, and tissue engineering. His postdoctoral training at McGill University and the University of Pittsburgh further solidified his expertise in gene therapy and skeletal muscle research. His multidisciplinary research approach bridges orthopaedic surgery, pathology, pediatrics, and molecular genetics.
Dr. Huard has led numerous high-impact international research collaborations and has served in pivotal roles, including Deputy Director at the McGowan Institute for Regenerative Medicine and Director of the Stem Cell Research Center at the University of Pittsburgh. His projects have attracted significant funding and institutional backing, enabling translational breakthroughs in muscle regeneration, orthopaedic repair, and cardiac therapies. He has mentored dozens of Ph.D. students and postdoctoral fellows, establishing a legacy of scientific leadership and academic mentorship.
His prolific publication record includes authorship in high-impact journals indexed in Scopus, IEEE, ASBMR, and Cell Transplantation, with extensive citation metrics reflecting his influence. His work has been featured on the covers of journals such as Stem Cells, Molecular Therapy, and Journal of Orthopaedic Research. He holds over 10 patents in stem cell therapy, gene delivery, and regenerative medicine applications, underscoring his contributions to innovation.
Dr. Huard’s leadership transcends research. He has served as Chair or Co-Chair for numerous scientific committees and symposia, including the Vail Scientific Summit and Orthopaedic Research Society (ORS) committees. He sits on editorial boards of over 15 peer-reviewed journals and has reviewed grants for the NIH, DOD, and Canadian research councils. His dedication to the scientific community is also evident through his extensive service on national and international review panels, organizing committees, and advisory boards.
His accolades include the Kappa Delta Award from the American Academy of Orthopaedic Surgeons, multiple New Investigator Recognition Awards (ORS), the Cabaud Memorial Award, and honorary degrees. His contributions have been consistently recognized for their societal impact, including treatments for Duchenne Muscular Dystrophy, osteoarthritis, and cardiovascular regeneration. He is a member of prestigious organizations such as AAAS, ISSCR, ASBMR, and the Orthopaedic Research Society, where he has also held elected positions.
🎓 Education
Dr. Huard began his academic journey at Gaspesie College, focusing on Pure & Health Sciences. He obtained his Bachelor’s degree in Biology from Rimouski University (U.Q.A.R.) in 1988, followed by both Master’s and Doctorate degrees in Neurobiology from Laval University. His graduate work investigated dystrophin localization at neuromuscular junctions and myoblast transplantation in Duchenne Muscular Dystrophy (DMD) models. His postdoctoral fellowships at McGill University and the University of Pittsburgh further developed his expertise in gene therapy and viral vector-based interventions for tissue regeneration.
đź’Ľ Experience
Dr. Huard’s academic career spans over 30 years and includes prestigious roles such as Henry J. Mankin Endowed Chair of Orthopaedic Surgery Research and Director of the Stem Cell Research Center at the University of Pittsburgh. He later served as Vice Chair for Research in Orthopaedic Surgery at UTHealth Houston. Currently, at the Steadman Philippon Research Institute, he leads numerous regenerative medicine initiatives that bridge basic science with clinical translation. He is also a devoted mentor, having trained more than 150 research fellows, clinicians, and junior faculty across the globe.
🔬 Research Focus
Dr. Huard’s research focuses on stem cell–based therapies for musculoskeletal and cardiovascular repair. He is internationally known for developing muscle-derived stem cells (MDSCs) that possess regenerative capabilities for cartilage, bone, and soft tissue injuries. His lab integrates biomaterials, gene therapy, and tissue engineering to advance personalized medicine for conditions related to aging, trauma, and degenerative diseases. His translational research has catalyzed several clinical trials and novel treatment platforms, particularly in orthopaedics, urology, and sports medicine.
🏅 Awards and Honors
Dr. Huard’s exemplary contributions have earned him over 120 prestigious awards. Notably, he received the Kappa Delta Ann Doner Vaughn Award (2018) from the American Academy of Orthopaedic Surgeons (AAOS) for pioneering research in orthopaedic science. He was recognized as a New Investigator Recognition Award Finalist by the Orthopaedic Research Society (ORS) in 2019 and 2024, and received the ON/AOSSM Orthoregeneration Awards in 2019, 2022, and 2023 for innovative research on Fisetin in osteochondral repair. His academic excellence was further acknowledged with an Honorary Doctorate from the University of Quebec (2019) and the Cabaud Memorial Award (2019) from the AOSSM for outstanding sports medicine research. These honors highlight his unparalleled impact on regenerative medicine and tissue engineering.
đź“š Publications Top Notes
A perivascular origin for mesenchymal stem cells in multiple human organs
Crisan M, Yap S, Casteilla L, Chen CW, … Huard J, Péault B
📌 Cell Stem Cell, 2008, 3(3): 301–313
🔍 Revealed that mesenchymal stem cells originate from perivascular niches in various tissues, reinforcing their regenerative potential and perivascular identity.
Identification of a novel population of muscle stem cells in mice: potential for muscle regeneration
Qu-Petersen Z, Deasy B, Jankowski R, … Huard J
📌 Journal of Cell Biology, 2002, 157(5): 851–864
🔍 Discovered MDSCs with superior regenerative capacity, showing effective repair in dystrophic and injured muscles in preclinical models.
Synergistic enhancement of bone formation and healing by stem cell–expressed VEGF and BMP-4
Peng H, Wright V, Usas A, … Huard J
📌 Journal of Clinical Investigation, 2002, 110(6): 751–759
🔍 Demonstrated enhanced angiogenesis and bone repair through co-expression of VEGF and BMP-4 in stem cells.
Muscle injuries and repair: current trends in research
Huard J, Li Y, Fu FH
📌 Journal of Bone and Joint Surgery, 2002, 84(5): 822–832
🔍 Reviewed advances in gene therapy, biomaterials, and cell-based treatments for skeletal muscle injury and regeneration.
Clonal isolation of muscle-derived cells capable of enhancing muscle regeneration and bone healing
Lee JY, Qu-Petersen Z, Cao B, … Huard J
📌 Journal of Cell Biology, 2000, 150(5): 1085–1100
🔍 Isolated unique progenitor cells with strong regenerative capacity for musculoskeletal applications.
🔚 Conclusion
Dr. Johnny Huard stands at the forefront of regenerative medicine, exemplifying a career defined by scientific leadership, innovation, and mentorship. With over 52,000 citations, an h-index of 119, and leadership in world-renowned institutions, his research has transformed the landscape of stem cell science and orthopedic regeneration. Beyond his scientific achievements, his mentorship has empowered a generation of researchers and clinicians to further his legacy. Dr. Huard is not only a trailblazer in regenerative therapies but also a worthy and inspiring nominee for the Best Researcher Award.